Company intelligence / Profile preview

DyNAbind

Dresden, Saxony, Germany

Ownership: Private
Development stage: Other

Overview

DyNAbind provides DNA-Encoded Library discovery and hit-validation services and products for partners; it does not appear to run its own therapeutic clinical programs but enables pre-clinical hit discovery and optimization against challenging targets, including membrane proteins.[1][3][4]

Modalities: Small molecule
Industry: Drug Discovery Services

Partnerships

Salipro Biotech (DEL screening of membrane proteins)MilliporeSigma (distribution of DEL kits for academic groups)

Beyond the preview

Go deeper on DyNAbind.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DyNAbind.

Explore the full profile